ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

BNGO vs PRPO // PIOTROSKI F-SCORE QUALITY

Bionano Genomics Inc. (NASDAQ) VS. Precipio Inc. (NASDAQ) • 15-METRIC TALLY: BNGO 2 — PRPO 6
▲ PIOTROSKI F-SCORE QUALITY LEADER: PRPO
piotroski-score
8/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BNGO VS. PRPO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC BNGO PRPO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 46.30% 44.20% +2.10 BNGO /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -7.90% -27.10 PRPO /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — 1.04% — TIE /fcf-yield <GO>
Operating Margin -60.00% -5.00% -55.00 PRPO /operating-margins <GO>
Net Profit Margin -60.00% -1.50% -58.50 PRPO /net-margins <GO>
Revenue Growth (YoY) -7.40% 30.50% -37.90 PRPO /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality ACTIVE 4/9 8/9 -4.00 PRPO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 34.4 25.4 +9.04 BNGO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $16.8M $34.6M -$17.9M PRPO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR BNGO REV PRPO REV BNGO GROSS % PRPO GROSS % BNGO FCF PRPO FCF
FY 2025 $28.5M $24.2M 46.3% 44.2% -$16.3M $359.0K
FY 2024 $30.8M $18.6M 1.2% 40.7% -$68.9M $216.0K
FY 2023 $36.1M $15.4M — — -$125.2M -$3.6M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BNGO // BETA —
PRPO // BETA —